Australia's most trusted
source of pharma news
Thursday, 26 March 2026
Posted 26 March 2026 AM
The PBAC has dropped a packed agenda ahead of its July meeting, featuring 50 submissions for consideration.
New PBS listing submissions dominate the list at 31, followed by 15 change to existing listing submissions, and one ‘other matters’ submission. The committee will also consider three DUSC analysis reports submitted by MSD, Astellas Pharma, and sponsors of Covid antivirals.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.